← AtriCure, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($33.3m) |
($26.9m)
+19.34%
|
($21.1m)
+21.40%
|
($35.2m)
-66.50%
|
($48.2m)
-36.83%
|
$50.2m
+204.24%
|
($46.5m)
-192.56%
|
($30.4m)
+34.49%
|
($44.7m)
-46.85%
|
($11.4m)
+74.39%
|
— | |
| Depreciation | $7.7m | $7.8m | $7.2m | $7.4m | $7.9m | $7.5m | $8.1m | $9.5m | $11.2m | $12.1m | $11.9m | |
| Amortization of Debt Issuance Costs | $218k | $264k | $515k | $375k | $509k | $759k | $507k | $486k | $478k | $478k | — | |
| Amortization of Intangible Assets | $1.6m | $1.4m | $1.5m | $1.9m | $1.7m | $2.9m | $3.7m | $5.4m | $7.5m | $8.4m | — | |
| Deferred Income Tax Expense (Benefit) | — | ($102k) | $51k | $26k | ($12k) | $21k | $8k | ($15k) | $6k | ($62k) | — | |
| Share-based Payment Arrangement, Noncash Expense | $11.7m | $14.6m | $16.5m | $18.0m | $22.6m | $28.1m | $28.8m | $35.7m | $40.4m | $44.7m | $47.3m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $1.7m | $2.0m | $4.5m | $9.0m | $13.0m | $18.0m | $12.2m | $6.6m | $7.0m | $11.2m | — | |
| Share-based Payment Arrangement, Expense | $11.7m | $14.6m | $16.5m | $18.0m | $22.6m | $28.1m | $28.8m | $35.7m | $40.4m | $44.7m | $47.3m | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | $82.3m | $0 | $0 | — | — | — | |
| Other Nonoperating Income (Expense) | ($586k) | $138k | ($183k) | ($160k) | ($24k) | ($366k) | ($537k) | ($31k) | ($326k) | $683k | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $2.0m | $1.5m | $2.8m | $3.2m | ($5.1m) | $10.1m | $9.0m | $9.9m | $8.3m | $5.6m | ($14.5m) | |
| Increase (Decrease) in Inventories | $79k | $4.5m | $146k | $5.2m | $5.3m | $4.3m | $7.3m | $21.8m | $7.7m | $2.3m | ($7.8m) | |
| Increase (Decrease) in Accounts Payable | ($1.1m) | $1.3m | ($2.4m) | $2.8m | ($1.6m) | $4.7m | $2.7m | $6.2m | ($1.5m) | ($960k) | $8.1m | |
| Net Cash Provided by (Used in) Operating Activities | ($15.1m) |
($8.9m)
+40.84%
|
($4.2m)
+53.37%
|
($15.8m)
-279.07%
|
($19.9m)
-25.67%
|
($13.8m)
+30.65%
|
($22.1m)
-60.67%
|
$4.5m
+120.25%
|
$12.2m
+172.17%
|
$57.3m
+369.80%
|
$64.9m
+13.26%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $7.7m | $6.4m | $6.2m | $12.2m | $5.3m | $9.8m | $16.9m | $12.0m | $11.5m | $9.1m | ($12.8m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($433k) | ($336k) | ($323k) | ($604k) | ($277k) | — | — | — | — | — | $1.4m | |
| Gain (Loss) on Investments | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Unrealized Gain (Loss) on Investments | ($21k) | ($6k) | ($37k) | $100k | $54k | ($887k) | ($3.7m) | ($800k) | — | — | — | |
| Net Cash Provided by (Used in) Investing Activities | ($12.1m) | $3.8m | ($85.4m) | ($2.1m) | ($156.2m) | $23.5m | $44.0m | $21.8m | $30.2m | ($14.6m) | ($12.8m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | $0 | $0 | ($1.4m) | $0 | — | |
| Proceeds from Issuance of Long-term Debt | — | — | — | $20.0m | — | $5.0m | $0 | $0 | $61.2m | $0 | $0 | |
| Proceeds from Issuance of Common Stock | $1.6m | $2.1m | $82.9m | $2.7m | $189.0m | $0 | $0 | $5.3m | $5.1m | $5.9m | $0 | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | — | — | — | — | $6.2m | — | |
| Net Cash Provided by (Used in) Financing Activities | $27.7m |
$2.8m
-90.03%
|
$100.2m
+3529.57%
|
$14.4m
-85.65%
|
$189.4m
+1217.69%
|
($7.6m)
-104.04%
|
($7.1m)
+7.63%
|
($32k)
+99.55%
|
($3.6m)
-11159.38%
|
$1.2m
+132.64%
|
($1.9m)
-262.50%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($53k) | $24k | ($179k) | ($3.7m) | $13.5m | $1.7m | $14.4m | $26.2m | $38.4m | $44.7m | $168.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $58.1m | $84.3m | $122.7m | $167.4m | $168.0m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($53k) | $24k | ($179k) | ($163k) | $136k | ($372k) | ($361k) | ($58k) | ($424k) | $747k | ($213k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $3.3m | $4.4m | $6.0m | $1.2m | $10.8m | $8.2m | $1.8m | $2.3m | $1.0m | $1.4m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $2.0m | $3.9m | $3.7m | $4.4m | $4.2m | $4.3m | $6.4m | $6.0m | $5.3m | — | |
| Income Taxes Paid, Net | — | — | $65k | $259k | $217k | $190k | $192k | $395k | $619k | $1.3m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($407k) | $173k | ($165k) | ($181k) | — | — | — | — | — | — | — | |
| Goodwill | $105.3m | $105.3m | $105.3m | $234.8m | $234.8m | $234.8m | $234.8m | $234.8m | $234.8m | $234.8m | — | |
| Income Tax Expense (Benefit) | $40k | $14k | $226k | $199k | $114k | $188k | $268k | $591k | $1.0m | $1.3m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $6.4m | $5.9m | — | |
| Investment Income, Interest | $227k | $227k | $1.0m | $2.4m | $1.1m | $466k | $2.0m | $3.8m | $4.4m | $4.5m | — | |
| Operating Expenses | $142.2m | $151.1m | $164.2m | $203.5m | $193.5m | $150.7m | $288.6m | $327.1m | $387.5m | $410.2m | — |